Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Figure 1 We first identified persons treated with metformin and GLP-1 RAs (the exposure drug) and/or DPP-4is (the control drug) between January 1 st 2005 and December 31 st 2019
doi: 10.1213/ane.0000000000006888 21
If you change your mind the same day - after the Rx is issued - that billing cycle isn't reversible
News Release: Tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes in two phase 3 trials from Lilly's SURPASS program
If you notice anything unusual, contact your care team
Safety and Efficacy of Once-Weekly Dulaglutide Versus Sitagliptin After 2 Years in Metformin-Treated Patients With Type 2 Diabetes (AWARD-5): A Randomized, Phase III Study
US$ 28.61
US$ 23.32
US$ 23.57
US$ 25.18
US$ 24.37
US$ 27.47
US$ 21.94
